Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
S.Korea’s Lunit installs breast cancer AI diagnostic tool at 200 US hospitals
Lunit Inc., a South Korean AI-powered cancer diagnostics company, said on Monday that more than 200 healthcare institutions across the US have now a...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
POSCO to sell entire stake in Nippon Steel, ending equity ties
POSCO Holdings Inc. has decided to sell its entire stake in Nippon Steel Corp., according to industry sources on Wednesday, marking the end of their...
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Dongkuk to file anti-dumping petition vs Chinese color steel imports
Dongkuk Coated Metal Co. and SeAh Steel Corp. are set to file an anti-dumping complaint against Chinese rivals in March as the country plans to impo...
South Korea to levy 38% anti-dumping duties on Chinese steel products
South Korea plans to impose up to 38% provisional anti-dumping duties on Chinese hot-rolled steel plates starting next month, judging that those pro...
Korea to probe Chinese, Japanese steel imports over anti-dumping claims
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
South Korea’s steel imports from China at 7-year high
South Korea’s imports of steel products from China climbed to their highest level in seven years despite a decrease in its total steel imports...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Korean paper makers to file anti-dumping complaint vs Japanese rivals
South Korean corrugated cardboard sheet makers such as Asia Paper Manufacturing Co. have decided to file an anti-dumping complaint against Japanese ...
President of Latvia visits S.Korea's Daan Cancer Lab
Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...
Hanmi Pharma to move up launch of anti-obesity drug
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca
Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...
Volpara to supply breast cancer SW to US Defense Health Agency
Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...
Czech anti-trust body puts signing of nuclear power deal on hold
The Czech anti-trust body put a temporary block on the conclusion of a contract with Korea Hydro & Nuclear Power Co. (KHNP) for the construction...
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
After 37 years of use, Kim returns trusty microwave to Samsung with love
For 37 years, a simple microwave made by Samsung Electronics Co. sat in the kitchen of Kim Kyu-won, providing much more than convenience.It was ther...
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Gencurix, Hitachi to cooperate on molecular diagnostics
South Korean biotech company Gencurix Inc. said on Tuesday that it will cooperate with Japan's Hitachi High-Tech Corporation to enter the Japanese c...
Samhwa Paint launches anti-rust product Knok-Stop
South Korea's Samhwa Paint Industrial said on Wednesday that it has introduced a new water-based primer, Knok-Stop, designed to convert rust on meta...
Volpara to supply cancer diagnostics SW to Intermountain Health
Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
S.Korea, China's technology leak, anti-dumping disputes surge
South Korean companies are getting tough on anti-dumping and patent infringement cases as they feel threatened by the intensifying price competition...
Lunit to supply AI cancer diagnostics to Qatar
Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Ins...
LG Energy Solution acquires anti-bribery certification
South Korea's LG Energy Solution Ltd. announced on Thursday that it achieved ISO 37001 certification, an international standard for anti-bribery man...
Lunit eyes developing markets with AI cancer diagnostics
Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagn...
